Top

Journal of Hepato-Biliary-Pancreatic Sciences

Published in:

01-01-2007

Antimicrobial therapy for acute cholangitis: Tokyo Guidelines

Authors: Atsushi Tanaka, Tadahiro Takada, Yoshifumi Kawarada, Yuji Nimura, Masahiro Yoshida, Fumihiko Miura, Masahiko Hirota, Keita Wada, Toshihiko Mayumi, Harumi Gomi, Joseph S. Solomkin, Steven M. Strasberg, Henry A. Pitt, Jacques Belghiti, Eduardo de Santibanes, Robert Padbury, Miin-Fu Chen, Giulio Belli, Chen-Guo Ker, Serafin C. Hilvano, Sheung-Tat Fan, Kui-Hin Liau

Published in: Journal of Hepato-Biliary-Pancreatic Sciences | Issue 1/2007

Abstract

Antimicrobial agents should be administered to all patients with suspected acute cholangitis as a priority as soon as possible. Bile cultures should be performed at the earliest opportunity. The important factors which should be considered in selecting antimicrobial therapy include the agent’s activity against potentially infecting bacteria, the severity of the cholangitis, the presence or absence of renal and hepatic diseases, the patient’s recent history of antimicrobial therapy, and any recent culture results, if available. Biliary penetration of the microbial agents should also be considered in the selection of antimicrobials, but activity against the infecting isolates is of greatest importance. If the causative organisms are identified, empirically chosen antimicrobial drugs should be replaced by narrower-spectrum antimicrobial agents, the most appropriate for the species and the site of the infection.

Pitt, HA, Postier, R, Cameron, J 1983Consequences of preoperative cholangitis and its treatment on the outcome of operation for choledocholithiasisSurgery9444752level 2bPubMed

Maluenda, F, Csendes, A, Burdiles, P, Diaz, J 1989Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitisHepatogastroenterology361325level 3bPubMed

Claesson, B 1986Microflora of the biliary tree and liver — clinical correlatesDig Dis493118level 5CrossRefPubMed

Chang, W, Lee, K, Wang, S, Chuang, S, Kuo, K, Chen, J, et al. 2002Bacteriology and antimicrobial susceptibility in biliary tract disease: an audit of 10-year’s experienceKaohsiung J Med Sci182218level 3bPubMed

Csendes, A, Burdiles, P, Maluenda, F, Diaz, J, Csendes, P, Mitru, N 1996Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stonesArch Surg13138994level 2bPubMed

Csendes, A, Mitru, N, Maluenda, F, Diaz, J, Burdiles, P, Csendes, P, et al. 1996Counts of bacteria and pyocites of choledochal bile in controls and in patients with gallstones or common bile duct stones with or without acute cholangitisHepatogastroenterology438006level 2bPubMed

Brismar, B, Jalakas, K, Malmborg, A, Strandberg, A 1986The significance of bacteriological findings at cholecystectomyActa Chir Scand530358level 3b

Jarvinen, H 1980Biliary bacteremia at various stages of acute cholecystitisActa Chir Scand14642730level 2bPubMed

Hanau, L, Steigbigel, N 2000Acute (ascending) cholangitisInfect Dis Clin North Am1452146level 4CrossRefPubMed

10.

Westphal, J, Brogard, J 1999Biliary tract infections: a guide to drug treatmentDrugs578191level 5CrossRefPubMed

11.

Sinanan, M 1992Acute cholangitisInfect Dis Clin North Am657199level 5PubMed

12.

Marne, C, Pallares, R, Martin, R, Sitges-Serra, A 1986Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bileEur J Clin Microbiol5359level 3bCrossRefPubMed

13.

Claesson, B, Holmlund, D, Matzsch, T 1986Microflora of the gallbladder related to duration of acute cholecystitisSurg Gynecol Obstet1625315level 2bPubMed

14.

Nielsen, M, Justesen, T 1976Anaerobic and aerobic bacteriological studies in biliary tract diseaseScand J Gastroenterol1143746level 3bPubMed

15.

Hanau, L, Steigbigel, N 1995Cholangitis: pathogenesis, diagnosis, and treatmentCurr Clin Top Infect Dis1515378level 4PubMed

16.

Thompson, JE,Jr, Bennion, R, Pitt, HA 1994An analysis of infectious failures in acute cholangitisHPB Surg813945level 4CrossRefPubMed

17.

Dellinger, RP, Carlet, JM, Masur, H, Gerlach, H, Calandra, T, Cohen, J, et al. 2004for the Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shockCrit Care Med3285873level 4CrossRefPubMed

18.

Gilbert, D, Moellering, R,Jr, Sande, M 2003The Sanford guide to antimicrobial therapy33rd edAntimicrobial therapyHyde Park, VTlevel 4

19.

Brunton, LLLazo, JSParker, KL eds. 2006Goodman and Gilman’s the pharmacological basis of therapeutics11th edMcGraw-HillNew Yorklevel 4

20.

Leung, J, Ling, T, Chan, R, Cheung, S, Lai, C, Sung, J, et al. 1994Antibiotics, biliary sepsis, and bile duct stonesGastrointest Endosc4071621level 3bPubMed

21.

Martinez, O, Levi, J, Devlin, R 1984Biliary excretion of aztreonam in patients with biliary tract diseaseAntimicrob Agents Chemother2535861level 4PubMed

22.

Leung, J, Chan, C, Lai, C, Ko, T, Cheng, A, French, G 1992Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatinAntimicrob Agents Chemother36205760level 3bPubMed

23.

Leung, J, Chan, R, Cheung, S, Sung, J, Chung, S, French, G 1990The effect of obstruction on the biliary excretion of cefoperazone and ceftazidimeJ Antimicrob Chemother25399406level 4CrossRefPubMed

24.

Blenkharn, J, Habib, N, Mok, D, John, L, McPherson, G, Gibson, R, et al. 1985Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundiceAntimicrob Agents Chemother2877880level 4PubMed

25.

van den Hazel, S, De Vries, X, Speelman, P, Dankert, J, Tytgat, G, Huibregtse, K, et al. 1996Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tractAntimicrob Agents Chemother40265860level 4PubMed

26.

Takada, T, Hanyu, F, Fukushima, Y, Uchida, Y, Imaizumi, T, Yasuda, H 1976Excretion of antibiotics into human bile juice in patients with obstructive jaundice (in Japanese)Jpn J Gastroenterol733947level 4

27.

Levi, J, Martinez, O, Malinin, T, Zeppa, R, Livingstone, A, Hutson, D, et al. 1984Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstructionAntimicrob Agents Chemother269446level 4PubMed

28.

Boey, J, Way, L 1980Acute cholangitisAnn Surg19126470level 5CrossRefPubMed

29.

Thompson, JE,Jr, Tompkins, R, Longmire, WJ 1982Factors in management of acute cholangitisAnn Surg19513745level 4PubMedCrossRef

30.

Muller, E, Pitt, HA, Thompson, JE,Jr, Doty, J, Mann, L, Manchester, B 1987Antibiotics in infections of the biliary tractSurg Gynecol Obstet16528592level 2bPubMed

31.

Gerecht, W, Henry, N, Hoffman, W, Muller, S, LaRusso, N, Rosenblatt, J, et al. 1989Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitisArch Intern Med149127984level 2bCrossRefPubMed

32.

Thompson, JE,Jr, Pitt, HA, Doty, J, Coleman, J, Irving, C 1990Broad spectrum penicillin as an adequate therapy for acute cholangitisSurg Gynecol Obstet17127582level 2bPubMed

33.

Chacon, J, Criscuolo, P, Kobata, C, Ferraro, J, Saad, S, Reis, C 1990Prospective randomized comparison of pefloxacin and ampicillin plus gentamicin in the treatment of bacteriologically proven biliary tract infectionsJ Antimicrob Chemother2616772level 2bPubMed

34.

Thompson, JE,Jr, Bennion, R, Roettger, R, Lally, K, Hopkins, J, Wilson, SE 1993Cefepime for infections of the biliary tractSurg Gynecol Obstet177304level 2bPubMed

35.

Sung, J, Lyon, D, Suen, R, Chung, S, Co, A, Cheng, A, et al. 1995Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trialJ Antimicrob Chemother3585564level 2bCrossRefPubMed

36.

Solomkin, J, Mazuski, J, Baron, E, Sawyer, R, Nathens, A, DiPiro, J, et al. 2003Guidelines for the selection of anti-infective agents for complicated intra-abdominal infectionsClin Infect Dis379971005level 4CrossRefPubMed

37.

Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group1994Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infectionsEur J Surg573616level 2b

38.

Sales, J, Sutcliffe, M, O’Grady, F 1973Excretion of clindamycin in the bile of patients with biliary tract diseaseChemotherapy19115level 4CrossRefPubMed

39.

Csendes, A, Becerra, M, Burdiles, P, Demian, I, Bancalari, K, Csendes, P 1994Bacteriological studies of bile from the gallbladder in patients with carcinoma of the gallbladder, cholelithiasis, common bile duct stones and no gallstones diseaseEur J Surg1603637level 2bPubMed

40.

Csendes, A, Fernandez, M, Uribe, P 1975Bacteriology of the gallbladder bile in normal subjectsAm J Surg12962931level 3bCrossRefPubMed

41.

Kune, G, Schutz, E 1974Bacteria in the billary tract. A study of their frequency and typeMed J Aust12558level 3bPubMed

42.

Orda, R, Berger, S, Levy, Y, Shnaker, A, Gorea, A 1992Penetration of ceftriaxone and cefoperazone into bile and gallbladder tissue in patients with acute cholecystitisDig Dis Sci3716913level 4CrossRefPubMed

Title: Antimicrobial therapy for acute cholangitis: Tokyo Guidelines
Authors: Atsushi Tanaka
Tadahiro Takada
Yoshifumi Kawarada
Yuji Nimura
Masahiro Yoshida
Fumihiko Miura
Masahiko Hirota
Keita Wada
Toshihiko Mayumi
Harumi Gomi
Joseph S. Solomkin
Steven M. Strasberg
Henry A. Pitt
Jacques Belghiti
Eduardo de Santibanes
Robert Padbury
Miin-Fu Chen
Giulio Belli
Chen-Guo Ker
Serafin C. Hilvano
Sheung-Tat Fan
Kui-Hin Liau
Publication date: 01-01-2007
Publisher: Springer-Verlag
Published in: Journal of Hepato-Biliary-Pancreatic Sciences / Issue 1/2007
Print ISSN: 1868-6974
Electronic ISSN: 1868-6982
DOI: https://doi.org/10.1007/s00534-006-1157-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Antimicrobial therapy for acute cholangitis: Tokyo Guidelines

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2007

Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines

Surgical treatment of patients with acute cholecystitis: Tokyo Guidelines

Unusual cases of acute cholecystitis and cholangitis: Tokyo Guidelines

Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis

Techniques of biliary drainage for acute cholangitis: Tokyo Guidelines

Need for criteria for the diagnosis and severity assessment of acute cholangitis and cholecystitis: Tokyo Guidelines